These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29273110)

  • 1. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.
    Malik K; Guttman-Yassky E
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S62-S64. PubMed ID: 29273110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata.
    Ito T; Kageyama R; Nakazawa S; Honda T
    Exp Dermatol; 2020 Aug; 29(8):726-732. PubMed ID: 32533873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
    Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.
    Kageyama R; Ito T; Hanai S; Morishita N; Nakazawa S; Fujiyama T; Honda T; Tokura Y
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases.
    Garzorz N; Alsisi M; Todorova A; Atenhan A; Thomas J; Lauffer F; Ring J; Schmidt-Weber C; Biedermann T; Eyerich S; Eyerich K
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2429-35. PubMed ID: 26416203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel therapeutic paradigm for patients with extensive alopecia areata.
    Renert-Yuval Y; Guttman-Yassky E
    Expert Opin Biol Ther; 2016 Aug; 16(8):1005-14. PubMed ID: 27164008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
    Katagiri K; Arakawa S; Hatano Y
    Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17 inhibition: is it the long-awaited savior for alopecia areata?
    Ramot Y; Marzani B; Pinto D; Sorbellini E; Rinaldi F
    Arch Dermatol Res; 2018 Jul; 310(5):383-390. PubMed ID: 29497840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of FcɛR1α immunopositive cells in alopecia areata with atopic dermatitis and a high titer of serum immunoglobulin E.
    Yoshimasu T; Uede M; Kanazawa N; Mikita N; Yamamoto Y; Ito T; Furukawa F
    Eur J Dermatol; 2014; 24(4):500-3. PubMed ID: 25266745
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic therapies in atopic dermatitis: The pipeline.
    Renert-Yuval Y; Guttman-Yassky E
    Clin Dermatol; 2017; 35(4):387-397. PubMed ID: 28709570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
    Guttman-Yassky E; Krueger JG
    Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab.
    Barroso-García B; Rial MJ; Molina A; Sastre J
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):420-421. PubMed ID: 30530389
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells.
    McElwee KJ; Hoffmann R; Freyschmidt-Paul P; Wenzel E; Kissling S; Sundberg JP; Zöller M
    J Invest Dermatol; 2002 Dec; 119(6):1426-33. PubMed ID: 12485450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
    Migayron L; Bordes S; Closs B; Seneschal J; Boniface K
    Front Immunol; 2024; 15():1405215. PubMed ID: 38868763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.
    Renert-Yuval Y; Guttman-Yassky E
    Adv Ther; 2017 Jul; 34(7):1594-1609. PubMed ID: 28646393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis.
    Numerof RP; Asadullah K
    BioDrugs; 2006; 20(2):93-103. PubMed ID: 16626167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia Areata: A Complex Cytokine Driven Disease.
    Song T; Guttman-Yassky E
    J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S55-S57. PubMed ID: 33099386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rates of vaccination among atopic dermatitis, alopecia areata, psoriasis, and psoriatic arthritis patients on biologics.
    Hren MG; Khattri S
    Arch Dermatol Res; 2024 May; 316(6):285. PubMed ID: 38796548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Darrigade AS; Legrand A; Andreu N; Jacquemin C; Boniface K; Taïeb A; Seneschal J
    Br J Dermatol; 2018 Aug; 179(2):534-536. PubMed ID: 29710431
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokines as therapeutic targets in skin inflammation.
    Wittmann M; McGonagle D; Werfel T
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):443-51. PubMed ID: 25164568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.